Headquarters
615 WESTLAKE AVE N, SEATTLE, WA 98109-4307, US
SEATTLE, WA, US
EPICURE THERAPEUTICS, INC.
From the company
EpiCure Therapeutics is advancing precision genetic therapies to target the abnormal brain circuits in epilepsy. Leveraging its discovery platform to target any brain cell type, the company has developed multiple assets with strong proof-of-concept data and plans to advance these therapies to the clinic to help patients and families.
Products & services offered
Capabilities 2
Facilities
Send your requirements
Quantities, certifications, and timing.